These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10202823)

  • 1. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.
    Foudraine NA; Hovenkamp E; Notermans DW; Meenhorst PL; Klein MR; Lange JM; Miedema F; Reiss P
    AIDS; 1999 Feb; 13(2):177-84. PubMed ID: 10202823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Mycobacterium xenopi disease in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Comparison with the pre-Haart period.
    Manfredi R; Nanetti A; Tadolini M; Calza L; Morelli S; Ferri M; Marinacci G
    Tuberculosis (Edinb); 2003; 83(5):319-28. PubMed ID: 12972345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
    Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
    Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.
    Cinti SK; Kaul DR; Sax PE; Crane LR; Kazanjian PH
    Clin Infect Dis; 2000 Mar; 30(3):511-4. PubMed ID: 10722436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium xenopi osteomyelitis in a patient on highly active antiretroviral therapy (HAART).
    Kulasegaram R; Richardson D; Macrae B; de Ruiter A
    Int J STD AIDS; 2001 Jun; 12(6):404-6. PubMed ID: 11368825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection.
    Manfredi R; Nanetti A; Morelli S; Ferri M; Valentini R; Calza L; Chiodo F
    HIV Clin Trials; 2004; 5(4):206-15. PubMed ID: 15472795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.
    Martínez E; Miró JM; González J; Mallolas J; Gatell JM
    AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection.
    Murray R; Mallal S; Heath C; French M
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):199-201. PubMed ID: 11347672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium xenopi infection in patients with human immunodeficiency virus infection.
    el-Helou P; Rachlis A; Fong I; Walmsley S; Phillips A; Salit I; Simor AE
    Clin Infect Dis; 1997 Aug; 25(2):206-10. PubMed ID: 9332511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Mycobacterium xenopi infection in AIDS patients treated with HAART in Hungary.
    Szlávik J; Sárvári C
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):701-3. PubMed ID: 14557921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
    Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
    J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?
    Kerbiriou L; Ustianowski A; Johnson MA; Gillespie SH; Miller RF; Lipman MC
    Clin Infect Dis; 2003 Nov; 37(9):1250-4. PubMed ID: 14557971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment.
    Bachmeyer C; Blum L; Stelianides S; Benchaa B; Gruat N; Danne O
    Sex Transm Infect; 2002 Feb; 78(1):60-1. PubMed ID: 11872863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.
    Behrens GM; Meyer D; Stoll M; Schmidt RE
    Immunobiology; 2000 Aug; 202(2):186-93. PubMed ID: 10993293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized Mycobacterium avium complex infection of vertebral and paravertebral structures in an HIV patient on highly active antiretroviral therapy.
    Corrales-Medina V; Symes S; Valdivia-Arenas M; Boulanger C
    South Med J; 2006 Feb; 99(2):174-7. PubMed ID: 16509558
    [No Abstract]   [Full Text] [Related]  

  • 17. If it isn't something, it's something else..
    Griffith DE
    South Med J; 2006 Feb; 99(2):112-3. PubMed ID: 16509546
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART.
    French MA
    AIDS Read; 1999 Nov; 9(8):548-9, 554-5, 559-62. PubMed ID: 11082733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment.
    Bachmeyer C; Blum L; Stelianides S; Benchaa B; Gruat N; Danne O
    Thorax; 2001 Dec; 56(12):978-9. PubMed ID: 11713363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.